HEADER TRANSFERASE/TRANSFERASE INHIBITOR 24-JUL-12 4G9R TITLE B-RAF V600E KINASE DOMAIN BOUND TO A TYPE II DIHYDROQUINAZOLINE TITLE 2 INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE B-RAF; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: KINASE DOMAIN (UNP RESIDUES 432-726); COMPND 5 SYNONYM: PROTO-ONCOGENE B-RAF, P94, V-RAF MURINE SARCOMA VIRAL COMPND 6 ONCOGENE HOMOLOG B1; COMPND 7 EC: 2.7.11.1; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BRAF, BRAF1, RAFB1; SOURCE 6 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: HIGH FIVE KEYWDS INHIBITOR, TYPE II, TRANSFERASE, KINASE, TRANSFERASE-TRANSFERASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR W.C.VOEGTLI,H.L.STURGIS REVDAT 2 28-FEB-24 4G9R 1 REMARK SEQADV REVDAT 1 14-NOV-12 4G9R 0 JRNL AUTH S.WENGLOWSKY,D.MORENO,E.R.LAIRD,S.L.GLOOR,L.REN,T.RISOM, JRNL AUTH 2 J.RUDOLPH,H.L.STURGIS,W.C.VOEGTLI JRNL TITL PYRAZOLOPYRIDINE INHIBITORS OF B-RAF(V600E). PART 4: JRNL TITL 2 RATIONAL DESIGN AND KINASE SELECTIVITY PROFILE OF CELL JRNL TITL 3 POTENT TYPE II INHIBITORS. JRNL REF BIOORG.MED.CHEM.LETT. V. 22 6237 2012 JRNL REFN ISSN 0960-894X JRNL PMID 22954737 JRNL DOI 10.1016/J.BMCL.2012.08.007 REMARK 2 REMARK 2 RESOLUTION. 3.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.24 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 13001 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.229 REMARK 3 R VALUE (WORKING SET) : 0.226 REMARK 3 FREE R VALUE : 0.277 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 678 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.28 REMARK 3 REFLECTION IN BIN (WORKING SET) : 925 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.2780 REMARK 3 BIN FREE R VALUE SET COUNT : 57 REMARK 3 BIN FREE R VALUE : 0.3330 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4174 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 68 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 36.21 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.82000 REMARK 3 B22 (A**2) : 0.82000 REMARK 3 B33 (A**2) : -1.64000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.514 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.415 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 24.949 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.895 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.850 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4336 ; 0.006 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5860 ; 1.005 ; 1.978 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 519 ; 5.179 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 188 ;34.478 ;23.936 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 785 ;18.455 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 26 ;18.066 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 639 ; 0.072 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3248 ; 0.002 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1999 ; 0.193 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2967 ; 0.306 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 119 ; 0.129 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 41 ; 0.186 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 2 ; 0.103 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2663 ; 0.361 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4198 ; 0.655 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1936 ; 0.469 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1662 ; 0.830 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4G9R COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 27-JUL-12. REMARK 100 THE DEPOSITION ID IS D_1000073916. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-DEC-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL7-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : SYNCHROTRON SILICON CRYSTAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 13727 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.200 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 200 DATA REDUNDANCY : 3.800 REMARK 200 R MERGE (I) : 0.14600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 5.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.37 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.6 REMARK 200 DATA REDUNDANCY IN SHELL : 4.00 REMARK 200 R MERGE FOR SHELL (I) : 0.36800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.14 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.80 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM TRIS, 16% PEG 8000, 100 MM NDSB REMARK 280 -256, PH 8.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 84.35900 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 48.41000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 48.41000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 42.17950 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 48.41000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 48.41000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 126.53850 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 48.41000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 48.41000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 42.17950 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 48.41000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 48.41000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 126.53850 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 84.35900 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: PROTEIN EXISTS IN EQUILIBRIUM BETWEEN MONOMER AND DIMER REMARK 300 STATES REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 420 REMARK 465 ASP A 421 REMARK 465 ARG A 422 REMARK 465 GLY A 423 REMARK 465 SER A 424 REMARK 465 HIS A 425 REMARK 465 HIS A 426 REMARK 465 HIS A 427 REMARK 465 HIS A 428 REMARK 465 HIS A 429 REMARK 465 HIS A 430 REMARK 465 GLY A 431 REMARK 465 SER A 432 REMARK 465 GLU A 433 REMARK 465 ASP A 434 REMARK 465 ARG A 435 REMARK 465 ASN A 436 REMARK 465 ARG A 437 REMARK 465 MET A 438 REMARK 465 LYS A 439 REMARK 465 THR A 440 REMARK 465 LEU A 441 REMARK 465 GLY A 442 REMARK 465 ARG A 443 REMARK 465 ARG A 444 REMARK 465 ASP A 445 REMARK 465 SER A 446 REMARK 465 SER A 447 REMARK 465 ARG A 603 REMARK 465 TRP A 604 REMARK 465 SER A 605 REMARK 465 GLY A 606 REMARK 465 SER A 607 REMARK 465 HIS A 608 REMARK 465 GLN A 609 REMARK 465 PHE A 610 REMARK 465 GLU A 611 REMARK 465 GLN A 612 REMARK 465 LEU A 613 REMARK 465 SER A 614 REMARK 465 PRO A 722 REMARK 465 LYS A 723 REMARK 465 ILE A 724 REMARK 465 HIS A 725 REMARK 465 ARG A 726 REMARK 465 MET B 420 REMARK 465 ASP B 421 REMARK 465 ARG B 422 REMARK 465 GLY B 423 REMARK 465 SER B 424 REMARK 465 HIS B 425 REMARK 465 HIS B 426 REMARK 465 HIS B 427 REMARK 465 HIS B 428 REMARK 465 HIS B 429 REMARK 465 HIS B 430 REMARK 465 GLY B 431 REMARK 465 SER B 432 REMARK 465 GLU B 433 REMARK 465 ASP B 434 REMARK 465 ARG B 435 REMARK 465 ASN B 436 REMARK 465 ARG B 437 REMARK 465 MET B 438 REMARK 465 LYS B 439 REMARK 465 THR B 440 REMARK 465 LEU B 441 REMARK 465 GLY B 442 REMARK 465 ARG B 443 REMARK 465 ARG B 444 REMARK 465 ASP B 445 REMARK 465 SER B 446 REMARK 465 SER B 447 REMARK 465 SER B 602 REMARK 465 ARG B 603 REMARK 465 TRP B 604 REMARK 465 SER B 605 REMARK 465 GLY B 606 REMARK 465 SER B 607 REMARK 465 HIS B 608 REMARK 465 GLN B 609 REMARK 465 PHE B 610 REMARK 465 GLU B 611 REMARK 465 GLN B 612 REMARK 465 LEU B 613 REMARK 465 SER B 614 REMARK 465 PRO B 722 REMARK 465 LYS B 723 REMARK 465 ILE B 724 REMARK 465 HIS B 725 REMARK 465 ARG B 726 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 522 CG CD CE NZ REMARK 470 LYS B 522 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 463 -81.54 -108.18 REMARK 500 PHE A 468 53.98 -118.67 REMARK 500 THR A 488 -95.85 -122.90 REMARK 500 ARG A 575 -11.17 76.50 REMARK 500 ASP A 576 51.66 -156.05 REMARK 500 ASP A 587 -4.73 63.91 REMARK 500 LYS A 601 79.02 -43.51 REMARK 500 ARG A 626 -147.08 -72.01 REMARK 500 ASP A 629 -96.13 15.65 REMARK 500 ASP A 677 91.67 -69.45 REMARK 500 SER A 720 76.54 -101.68 REMARK 500 ASN B 486 -87.87 -18.45 REMARK 500 VAL B 487 -79.07 69.29 REMARK 500 THR B 488 -159.25 -113.79 REMARK 500 GLN B 524 155.81 174.01 REMARK 500 ARG B 575 -21.52 76.96 REMARK 500 ASP B 587 2.60 59.58 REMARK 500 ARG B 626 -166.82 -68.18 REMARK 500 GLN B 628 -150.39 -106.98 REMARK 500 LYS B 630 -39.88 -26.80 REMARK 500 PRO B 686 152.67 -48.89 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE B1E A 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE B1E B 801 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4G9C RELATED DB: PDB DBREF 4G9R A 432 726 UNP P15056 BRAF_HUMAN 432 726 DBREF 4G9R B 432 726 UNP P15056 BRAF_HUMAN 432 726 SEQADV 4G9R MET A 420 UNP P15056 EXPRESSION TAG SEQADV 4G9R ASP A 421 UNP P15056 EXPRESSION TAG SEQADV 4G9R ARG A 422 UNP P15056 EXPRESSION TAG SEQADV 4G9R GLY A 423 UNP P15056 EXPRESSION TAG SEQADV 4G9R SER A 424 UNP P15056 EXPRESSION TAG SEQADV 4G9R HIS A 425 UNP P15056 EXPRESSION TAG SEQADV 4G9R HIS A 426 UNP P15056 EXPRESSION TAG SEQADV 4G9R HIS A 427 UNP P15056 EXPRESSION TAG SEQADV 4G9R HIS A 428 UNP P15056 EXPRESSION TAG SEQADV 4G9R HIS A 429 UNP P15056 EXPRESSION TAG SEQADV 4G9R HIS A 430 UNP P15056 EXPRESSION TAG SEQADV 4G9R GLY A 431 UNP P15056 EXPRESSION TAG SEQADV 4G9R GLU A 600 UNP P15056 VAL 600 ENGINEERED MUTATION SEQADV 4G9R MET B 420 UNP P15056 EXPRESSION TAG SEQADV 4G9R ASP B 421 UNP P15056 EXPRESSION TAG SEQADV 4G9R ARG B 422 UNP P15056 EXPRESSION TAG SEQADV 4G9R GLY B 423 UNP P15056 EXPRESSION TAG SEQADV 4G9R SER B 424 UNP P15056 EXPRESSION TAG SEQADV 4G9R HIS B 425 UNP P15056 EXPRESSION TAG SEQADV 4G9R HIS B 426 UNP P15056 EXPRESSION TAG SEQADV 4G9R HIS B 427 UNP P15056 EXPRESSION TAG SEQADV 4G9R HIS B 428 UNP P15056 EXPRESSION TAG SEQADV 4G9R HIS B 429 UNP P15056 EXPRESSION TAG SEQADV 4G9R HIS B 430 UNP P15056 EXPRESSION TAG SEQADV 4G9R GLY B 431 UNP P15056 EXPRESSION TAG SEQADV 4G9R GLU B 600 UNP P15056 VAL 600 ENGINEERED MUTATION SEQRES 1 A 307 MET ASP ARG GLY SER HIS HIS HIS HIS HIS HIS GLY SER SEQRES 2 A 307 GLU ASP ARG ASN ARG MET LYS THR LEU GLY ARG ARG ASP SEQRES 3 A 307 SER SER ASP ASP TRP GLU ILE PRO ASP GLY GLN ILE THR SEQRES 4 A 307 VAL GLY GLN ARG ILE GLY SER GLY SER PHE GLY THR VAL SEQRES 5 A 307 TYR LYS GLY LYS TRP HIS GLY ASP VAL ALA VAL LYS MET SEQRES 6 A 307 LEU ASN VAL THR ALA PRO THR PRO GLN GLN LEU GLN ALA SEQRES 7 A 307 PHE LYS ASN GLU VAL GLY VAL LEU ARG LYS THR ARG HIS SEQRES 8 A 307 VAL ASN ILE LEU LEU PHE MET GLY TYR SER THR LYS PRO SEQRES 9 A 307 GLN LEU ALA ILE VAL THR GLN TRP CYS GLU GLY SER SER SEQRES 10 A 307 LEU TYR HIS HIS LEU HIS ILE ILE GLU THR LYS PHE GLU SEQRES 11 A 307 MET ILE LYS LEU ILE ASP ILE ALA ARG GLN THR ALA GLN SEQRES 12 A 307 GLY MET ASP TYR LEU HIS ALA LYS SER ILE ILE HIS ARG SEQRES 13 A 307 ASP LEU LYS SER ASN ASN ILE PHE LEU HIS GLU ASP LEU SEQRES 14 A 307 THR VAL LYS ILE GLY ASP PHE GLY LEU ALA THR GLU LYS SEQRES 15 A 307 SER ARG TRP SER GLY SER HIS GLN PHE GLU GLN LEU SER SEQRES 16 A 307 GLY SER ILE LEU TRP MET ALA PRO GLU VAL ILE ARG MET SEQRES 17 A 307 GLN ASP LYS ASN PRO TYR SER PHE GLN SER ASP VAL TYR SEQRES 18 A 307 ALA PHE GLY ILE VAL LEU TYR GLU LEU MET THR GLY GLN SEQRES 19 A 307 LEU PRO TYR SER ASN ILE ASN ASN ARG ASP GLN ILE ILE SEQRES 20 A 307 PHE MET VAL GLY ARG GLY TYR LEU SER PRO ASP LEU SER SEQRES 21 A 307 LYS VAL ARG SER ASN CYS PRO LYS ALA MET LYS ARG LEU SEQRES 22 A 307 MET ALA GLU CYS LEU LYS LYS LYS ARG ASP GLU ARG PRO SEQRES 23 A 307 LEU PHE PRO GLN ILE LEU ALA SER ILE GLU LEU LEU ALA SEQRES 24 A 307 ARG SER LEU PRO LYS ILE HIS ARG SEQRES 1 B 307 MET ASP ARG GLY SER HIS HIS HIS HIS HIS HIS GLY SER SEQRES 2 B 307 GLU ASP ARG ASN ARG MET LYS THR LEU GLY ARG ARG ASP SEQRES 3 B 307 SER SER ASP ASP TRP GLU ILE PRO ASP GLY GLN ILE THR SEQRES 4 B 307 VAL GLY GLN ARG ILE GLY SER GLY SER PHE GLY THR VAL SEQRES 5 B 307 TYR LYS GLY LYS TRP HIS GLY ASP VAL ALA VAL LYS MET SEQRES 6 B 307 LEU ASN VAL THR ALA PRO THR PRO GLN GLN LEU GLN ALA SEQRES 7 B 307 PHE LYS ASN GLU VAL GLY VAL LEU ARG LYS THR ARG HIS SEQRES 8 B 307 VAL ASN ILE LEU LEU PHE MET GLY TYR SER THR LYS PRO SEQRES 9 B 307 GLN LEU ALA ILE VAL THR GLN TRP CYS GLU GLY SER SER SEQRES 10 B 307 LEU TYR HIS HIS LEU HIS ILE ILE GLU THR LYS PHE GLU SEQRES 11 B 307 MET ILE LYS LEU ILE ASP ILE ALA ARG GLN THR ALA GLN SEQRES 12 B 307 GLY MET ASP TYR LEU HIS ALA LYS SER ILE ILE HIS ARG SEQRES 13 B 307 ASP LEU LYS SER ASN ASN ILE PHE LEU HIS GLU ASP LEU SEQRES 14 B 307 THR VAL LYS ILE GLY ASP PHE GLY LEU ALA THR GLU LYS SEQRES 15 B 307 SER ARG TRP SER GLY SER HIS GLN PHE GLU GLN LEU SER SEQRES 16 B 307 GLY SER ILE LEU TRP MET ALA PRO GLU VAL ILE ARG MET SEQRES 17 B 307 GLN ASP LYS ASN PRO TYR SER PHE GLN SER ASP VAL TYR SEQRES 18 B 307 ALA PHE GLY ILE VAL LEU TYR GLU LEU MET THR GLY GLN SEQRES 19 B 307 LEU PRO TYR SER ASN ILE ASN ASN ARG ASP GLN ILE ILE SEQRES 20 B 307 PHE MET VAL GLY ARG GLY TYR LEU SER PRO ASP LEU SER SEQRES 21 B 307 LYS VAL ARG SER ASN CYS PRO LYS ALA MET LYS ARG LEU SEQRES 22 B 307 MET ALA GLU CYS LEU LYS LYS LYS ARG ASP GLU ARG PRO SEQRES 23 B 307 LEU PHE PRO GLN ILE LEU ALA SER ILE GLU LEU LEU ALA SEQRES 24 B 307 ARG SER LEU PRO LYS ILE HIS ARG HET B1E A 801 34 HET B1E B 801 34 HETNAM B1E 3-(2-CYANOPROPAN-2-YL)-N-{4-METHYL-3-[(3-METHYL-4-OXO- HETNAM 2 B1E 3,4-DIHYDROQUINAZOLIN-6-YL)AMINO]PHENYL}BENZAMIDE FORMUL 3 B1E 2(C27 H25 N5 O2) HELIX 1 1 THR A 491 ARG A 506 1 16 HELIX 2 2 LEU A 537 ILE A 543 1 7 HELIX 3 3 GLU A 549 LYS A 570 1 22 HELIX 4 4 SER A 616 MET A 620 5 5 HELIX 5 5 ALA A 621 ARG A 626 1 6 HELIX 6 6 SER A 634 GLY A 652 1 19 HELIX 7 7 ASN A 661 ARG A 671 1 11 HELIX 8 8 ASP A 677 VAL A 681 5 5 HELIX 9 9 PRO A 686 LEU A 697 1 12 HELIX 10 10 LYS A 700 ARG A 704 5 5 HELIX 11 11 LEU A 706 SER A 720 1 15 HELIX 12 12 THR B 491 ARG B 506 1 16 HELIX 13 13 SER B 536 ILE B 543 1 8 HELIX 14 14 GLU B 549 LYS B 570 1 22 HELIX 15 15 GLU B 586 LEU B 588 5 3 HELIX 16 16 ALA B 621 ARG B 626 1 6 HELIX 17 17 SER B 634 GLY B 652 1 19 HELIX 18 18 ASN B 661 ARG B 671 1 11 HELIX 19 19 ASP B 677 VAL B 681 5 5 HELIX 20 20 PRO B 686 LEU B 697 1 12 HELIX 21 21 LYS B 700 ARG B 704 5 5 HELIX 22 22 LEU B 706 SER B 720 1 15 SHEET 1 A 5 THR A 458 GLY A 466 0 SHEET 2 A 5 GLY A 469 LYS A 475 -1 O VAL A 471 N GLY A 464 SHEET 3 A 5 ASP A 479 MET A 484 -1 O VAL A 482 N TYR A 472 SHEET 4 A 5 ALA A 526 GLN A 530 -1 O THR A 529 N ALA A 481 SHEET 5 A 5 PHE A 516 SER A 520 -1 N GLY A 518 O VAL A 528 SHEET 1 B 3 GLY A 534 SER A 536 0 SHEET 2 B 3 ILE A 582 HIS A 585 -1 O LEU A 584 N SER A 535 SHEET 3 B 3 THR A 589 ILE A 592 -1 O LYS A 591 N PHE A 583 SHEET 1 C 5 THR B 458 GLY B 466 0 SHEET 2 C 5 GLY B 469 LYS B 475 -1 O VAL B 471 N ILE B 463 SHEET 3 C 5 ASP B 479 MET B 484 -1 O VAL B 480 N GLY B 474 SHEET 4 C 5 ALA B 526 GLN B 530 -1 O THR B 529 N ALA B 481 SHEET 5 C 5 PHE B 516 SER B 520 -1 N GLY B 518 O VAL B 528 SHEET 1 D 2 ILE B 582 HIS B 585 0 SHEET 2 D 2 THR B 589 ILE B 592 -1 O LYS B 591 N PHE B 583 CISPEP 1 LYS A 522 PRO A 523 0 3.69 SITE 1 AC1 13 ALA A 481 LYS A 483 GLU A 501 LEU A 514 SITE 2 AC1 13 ILE A 527 THR A 529 GLN A 530 TRP A 531 SITE 3 AC1 13 CYS A 532 HIS A 574 GLY A 593 ASP A 594 SITE 4 AC1 13 PHE A 595 SITE 1 AC2 12 ALA B 481 LYS B 483 GLU B 501 LEU B 514 SITE 2 AC2 12 THR B 529 GLN B 530 TRP B 531 CYS B 532 SITE 3 AC2 12 HIS B 574 GLY B 593 ASP B 594 PHE B 595 CRYST1 96.820 96.820 168.718 90.00 90.00 90.00 P 41 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010328 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010328 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005927 0.00000